Oncofoetal insulin receptor isoform A marks the tumour endothelium; an underestimated pathway during tumour angiogenesis and angiostatic treatment
Published inBritish Journal of Cancer, vol. 120, no. 2, p. 218-228
Publication date2019
Abstract
Keywords
- Animals
- Antigens, CD/genetics
- Cell Proliferation/genetics
- Chick Embryo
- Chorioallantoic Membrane/metabolism/pathology
- Disease Models, Animal
- Endothelium/metabolism/pathology
- Female
- Gene Knockdown Techniques
- Genome, Human/genetics
- Human Umbilical Vein Endothelial Cells
- Humans
- Insulin/genetics/metabolism
- Kidney Neoplasms/genetics/pathology
- Male
- Mice
- Neovascularization, Pathologic/genetics/pathology
- Protein Isoforms/genetics
- RNA, Small Interfering/genetics
- Receptor, Insulin/genetics
- Tumor Cells, Cultured
Affiliation
Research group
Citation (ISO format)
NOWAK-SLIWINSKA, Patrycja et al. Oncofoetal insulin receptor isoform A marks the tumour endothelium; an underestimated pathway during tumour angiogenesis and angiostatic treatment. In: British Journal of Cancer, 2019, vol. 120, n° 2, p. 218–228. doi: 10.1038/s41416-018-0347-8
Main files (1)
Article (Published version)
Identifiers
- PID : unige:140706
- DOI : 10.1038/s41416-018-0347-8
- PMID : 30559346
ISSN of the journal0007-0920